Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of Onapristone and Anastrozole for refractory hormone receptor-positive endometrial cancer…
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: MK-3475 Immunotherapy in Endometrial Carcinoma [Phase 1]
Phase 1 trial evaluating pembrolizumab (MK-3475) in endometrial cancer has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer [Phase 2]
A Phase 2 study of ONC201 as a single agent in recurrent or metastatic endometrial cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer [Phase 2]
A Phase 2 study of ONC201 in recurrent Type II endometrial cancer was terminated, with results posted on 2024-12-24.
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Oral AMXT 1501 Dicaprate in Combination With IV DFMO [Phase 1, Phase 2]
A Phase 1/2 trial of oral AMXT 1501 dicaprate in combination with IV DFMO has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients [Phase 2]
Phase 2 trial evaluating metformin in combination with a levonorgestrel-releasing intrauterine system for Complex atypical hyperplasia of th…
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 trial evaluating NC410 in combination with pembrolizumab for advanced unresectable or metastatic solid tumors across mul…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Enhanced Recovery After Surgery (ERAS) for Laparoscopic Hysterectomy at Low Risk Endometrial Cancer [Phase 3]
A Phase 3 trial evaluating enhanced recovery after surgery (ERAS) protocols for laparoscopic hysterectomy in low-risk endometrial cancer has…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: UTOLA: UTerin OLAparib [Phase 2]
Phase 2 trial of olaparib for endometrial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer Cells [NA]
A completed clinical trial conducted in Thailand evaluating the effectiveness of metformin on a proliferative marker in endometrial cancer c…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy? [NA]
A completed pilot study evaluated ultrasound-guided biopsy as an alternative to hysteroscopy for evaluating endometrial conditions; results …
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: FPA150 in Patients With Advanced Solid Tumors [EARLY_Phase 1]
This early-phase 1 trial of FPA150 in breast cancer, ovarian cancer, and endometrial cancer has been terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating online adaptive radiotherapy as postoperative treatment for endometrial and cervical cancer is current…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Single-Port Hysterectomy (R-SPH) Using the Da Vinci SP System in Low-Risk Endometrial Cancer [NA]
This clinical trial update shows that a study evaluating single-port hysterectomy (R-SPH) with the Da Vinci SP system in low-risk endometria…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer [Phase 1]
Phase 1 study evaluating VSV-hIFNbeta-NIS with or without ruxolitinib phosphate in stage IV or recurrent endometrial cancer; results were po…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix [NA]
The clinical trial evaluating proton beam teletherapy after hysterectomy for endometrial and cervical cancers has completed and results have…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: ZW25 in Women With Endometrial Cancers [Phase 2]
Phase 2 trial of ZW25 in women with endometrial cancer and uterine carcinosarcoma has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]
Clinical trial update reporting safety, pharmacokinetics, and efficacy findings for tinostamustine in patients with advanced solid tumors, i…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension Study [Phase 3]
A Phase 3 China-extension trial comparing pembrolizumab plus lenvatinib versus chemotherapy in endometrial cancer has completed and posted r…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) [Phase 3]
Phase 3 trial comparing pembrolizumab plus lenvatinib to chemotherapy in endometrial cancer has completed with results posted in October 202…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Strain-elastography in Endometrial Cancer
A clinical trial evaluating strain-elastography in endometrial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway [Phase 1]
This clinical trial update describes a Phase 1 study of the PARP inhibitor DAT-2645 monotherapy for advanced/metastatic solid tumors harbori…
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: A Study of Patients Receiving High-Dose Rate Brachytherapy [Phase 2]
A Phase 2 study of high-dose-rate brachytherapy in patients with cervical cancer, endometrial cancer, esophageal cancer, prostate cancer, an…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Connecting Audio and Radio Sensing Systems to Improve Care at Home
Completed study evaluating an audio and radio sensing system to support at-home care for cancer patients. The trial enrolled participants wi…
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures [Phase 3]
Phase 3 pilot trial evaluating redosing liposomal bupivacaine for pain control in major gynecologic procedures has been terminated.